WallStreetZenWallStreetZen

NASDAQ: AEZS
Aeterna Zentaris Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AEZS

Based on 1 analyst offering 12 month price targets for Aeterna Zentaris Inc.
Min Forecast
$15.00+666.48%
Avg Forecast
$15.00+666.48%
Max Forecast
$15.00+666.48%

Should I buy or sell AEZS stock?

Based on 1 analyst offering ratings for Aeterna Zentaris Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AEZS stock forecasts and price targets.

AEZS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-13

1 of 1

Forecast return on equity

Is AEZS forecast to generate an efficient return?

Forecast return on assets

Is AEZS forecast to generate an efficient return on assets?

AEZS revenue forecast

What is AEZS's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.3M-4%

AEZS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AEZS$1.96$15.00+666.48%Buy
ASLN$0.54$9.50+1,659.26%Strong Buy
BRTX$1.44N/AN/A
PBM$0.68N/AN/A
PPBT$0.46$10.50+2,177.66%Strong Buy
View Top Biotech Stocks

Aeterna Zentaris Stock Forecast FAQ

Is Aeterna Zentaris Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AEZS) stock is to Buy AEZS stock.

Out of 1 analyst, 0 (0%) are recommending AEZS as a Strong Buy, 1 (100%) are recommending AEZS as a Buy, 0 (0%) are recommending AEZS as a Hold, 0 (0%) are recommending AEZS as a Sell, and 0 (0%) are recommending AEZS as a Strong Sell.

If you're new to stock investing, here's how to buy Aeterna Zentaris stock.

What is AEZS's revenue growth forecast for 2024-2024?

(NASDAQ: AEZS) Aeterna Zentaris's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Aeterna Zentaris's revenue in 2024 is $4,498,000.

In 2024, AEZS is forecast to generate $20,967,673 in revenue, with the lowest revenue forecast at $20,967,673 and the highest revenue forecast at $20,967,673.

What is AEZS's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: AEZS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -1%.

What is AEZS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AEZS price target, the average AEZS price target is $15.00, with the highest AEZS stock price forecast at $15.00 and the lowest AEZS stock price forecast at $15.00.

The Wall Street analyst predicted that Aeterna Zentaris's share price could reach $15.00 by Nov 13, 2024. The average Aeterna Zentaris stock price prediction forecasts a potential upside of 666.48% from the current AEZS share price of $1.96.

What is AEZS's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: AEZS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.